Shares of Dr Reddys Labs were trading lower at Rs 1,264.70, a 1.19% decrease, making it one of the top losers on the Nifty 50 index as of 2:00 pm on Tuesday. Other top losers on Nifty 50 were Asian Paints, Cipla, ICICI Bank and Kotak Mahindra.
Key financial data for Dr Reddys Labs reveals trends in revenue and profitability. Consolidated revenue for the year ending March 2025 stood at Rs 33,905.62 Crore, while net profit was Rs 3,569.00 Crore. The earnings per share (EPS) was Rs 38.25. For the quarter ending June 2025, the company reported revenue of Rs 8,938.55 Crore, net profit of Rs 1,080.73 Crore and an EPS of Rs 11.47.
| Financial Year | Revenue (Rs Crore) | Net Profit (Rs Crore) | EPS (Rs) |
|---|---|---|---|
| Mar 2021 | 21,712.79 | 3,178.15 | 32.73 |
| Mar 2022 | 29,101.28 | 3,053.24 | 31.59 |
| Mar 2023 | 34,488.59 | 4,101.48 | 42.83 |
| Mar 2024 | 35,494.73 | 5,424.69 | 56.95 |
| Mar 2025 | 33,905.62 | 3,569.00 | 38.25 |
The revenue for the year ending March 2024 was Rs 35,494.73 crore, and for the year ending March 2023, it was Rs 34,488.59 crore. The net profit for these years was Rs 5,424.69 crore and Rs 4,101.48 crore, respectively. The EPS for the corresponding years was Rs 56.95 and Rs 42.83.
| Quarter | Revenue (Rs Crore) | Net Profit (Rs Crore) | EPS (Rs) |
|---|---|---|---|
| Jun 2024 | 8,969.73 | 1,150.07 | 12.20 |
| Sep 2024 | 8,027.54 | 662.54 | 7.25 |
| Dec 2024 | 8,549.44 | 1,078.61 | 11.58 |
| Mar 2025 | 8,358.91 | 677.78 | 7.22 |
| Jun 2025 | 8,938.55 | 1,080.73 | 11.47 |
In terms of quarterly performance, the revenue for June 2024 was Rs 8,969.73 crore with a net profit of Rs 1,150.07 crore and EPS of Rs 12.20. By September 2024, revenue decreased to Rs 8,027.54 crore with a net profit of Rs 662.54 crore and EPS of Rs 7.25. December 2024 saw a revenue of Rs 8,549.44 crore, a net profit of Rs 1,078.61 crore, and EPS of Rs 11.58. March 2025 recorded revenue of Rs 8,358.91 crore, net profit of Rs 677.78 crore and EPS of Rs 7.22. The most recent quarter, June 2025, showed revenue at Rs 8,938.55 crore, net profit at Rs 1,080.73 crore, and EPS at Rs 11.47.
The company has a history of corporate actions, including dividends. However, there is no recent announcement about dividends.
As of Tuesday afternoon, Dr Reddys Labs shares were trading among the Nifty 50's top losers, reflecting the overall market sentiment.
As of Tuesday afternoon, Dr Reddys Labs shares were trading among the Nifty 50's top losers, reflecting the overall market sentiment.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
Find the best of Al News in one place, specially curated for you every weekend.
Stay on top of the latest tech trends and biggest startup news.
